According to the Saxenda Summary of Product Characteristics, treatment should be discontinued if less than 5% weight loss is achieved after 12 weeks on the maintenance dose of 3.0 mg daily Blood pressure and heart rate : Saxenda can increase heart rate, so cardiovascular parameters should be monitored regularly Blood glucose levels : Particularly important for patients with type 2 diabetes or prediabetes, as weight loss and GLP-1 agonist effects can improve glycaemic control Lipid profile and other metabolic markers : To assess improvement in cardiovascular risk factors Mental health and wellbeing : Weight loss can affect mood, and any concerns about depression or suicidal thoughts should be reported immediately Managing common gastrointestinal side effects involves eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and allowing time for your body to adjust to each dose increase

Most participants who experienced nausea during the initial titration phase reported significant improvement or complete resolution by weeks 4 to 8 at a stable dose
[1] [2] In 2024, Wegovy also received FDA approval to reduce cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight
In general, the usual dose is one tablet per day, taken with food
The cost ranges from $50 to $800 per month without insurance
Discuss dose timing and titration schedule with your doctor to achieve safe, effective results